I-131 Metaiodobenzylguanidine Uptake in a Parathyroid Adenoma
- 1 September 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 13 (9) , 632-634
- https://doi.org/10.1097/00003072-198809000-00002
Abstract
We describe a patient with multicentric small bowel carcinoids, severe hypertension, primary hyperparathyroidism, and multiple parathyroid adenomas. Intense uptake of I-131 metaiodobenzylguanidine (MIBG) occurred in a parathyroid adenoma. There was no biochemical evidence of catecholamine secretion by the tumor but elevated serum levels of parathyroid hormone were demonstrated. We suspect that occasional parathyroid adenomas, like other APUDomas, may give false positive results when MIBG imaging is used to search for pheochromocytomas. This observation supports the inclusion of the parathyroid chief cells in the amine precursor uptake and decarboxylation (APUD) cell system.This publication has 7 references indexed in Scilit:
- I-131 METAIODOBENZYLGUANIDINE SCINTIGRAPHY OF CARCINOID-TUMORS1986
- MULTIPLE GASTRIC CARCINOIDS IN A PATIENT WITH A HISTORY OF PRIMARY HYPERPARATHYROIDISM1985
- I-131 METAIODOBENZYLGUANIDINE FOR THE LOCATING OF SUSPECTED PHEOCHROMOCYTOMA - EXPERIENCE IN 400 CASES1985
- The location of middle mediastinal pheochromocytomasThe Journal of Thoracic and Cardiovascular Surgery, 1984
- MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATIONClinical Endocrinology, 1984
- SALIVARY-GLAND ACCUMULATION OF META-[I-131]IODOBENZYLGUANIDINE1984
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981